Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05511376
Other study ID # BAUGOZDEIN1318303
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date July 1, 2021
Est. completion date August 26, 2022

Study information

Verified date August 2022
Source Bahçesehir University
Contact Gözde IN
Phone +905314906736
Email dytgozdein@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Although obesity is a rapidly increasing epidemic worldwide, it is associated with many health-related comorbidities. As a result of the developments in social life and observes the sedentary life in individuals, an effect of the age of technology the fact that this epidemic will cause even massive health problems in the coming period affecting the health systems of countries and indirectly their economies that, This situation necessitates the creation of alternative treatment methods for the prevention of obesity. This study aims to determine the effect of a therapy approach that can be applied to the vagus nervous system, which is associated with many organs and systems, on weight loss and general health. As an alternative treatment against lifestyle changes such as diet and exercise, individuals have made for weight loss.


Recruitment information / eligibility

Status Recruiting
Enrollment 90
Est. completion date August 26, 2022
Est. primary completion date August 1, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Age range 18 - 65 - Being in the stage I, II and III obesity class Exclusion Criteria: - Those with unstable DM - Those with stage II hypertension - Those who have had cardiovascular disease (especially those who have had an attack) - Those with pulmonary disease - Those with kidney disease - Orthopedic restrictions - Those with MND - Those tied to the chair

Study Design


Related Conditions & MeSH terms


Intervention

Device:
AURICULAR VAGUS NERVE STIMULATION
For 4 weeks With the Vagustim device, in Biphasic, Frequency 10 Hz, Modulation mode, the pulse width of 300 µs, where the participants feel comfortable, the current intensity is kept constant for 30 minutes / 3 days/week. It will be applied as bilateral VSS from the tragus and turbinate parts of the ear.
Behavioral:
DIET
For 4 weeks, Protein intake to 30% of total daily calories or 1-1.2 g/kg Personal nutrition program created for ideal body weight (by BMI values for age)
EXERCISE
Exercise: Moderate Resistance Exercise Protocol (60 min 3 days a week )+ 30 min/day as aerobic exercise ( 5 days a week)

Locations

Country Name City State
Turkey Avicenna Hospital Istanbul

Sponsors (1)

Lead Sponsor Collaborator
Bahçesehir University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Body Analysis BIA measurements include (BMI (kg/m2)). Study start
Primary Body Analysis BIA measurements include (BMI (kg/m2)). 2nd week
Primary Body Analysis BIA measurements include (BMI (kg/m2)). 4th week
Primary Body Analysis BIA measurements include (Weight ( kg), Muscle and fat mass (kg), Body bone and fluid mass (kg), such as). Study start
Primary Body Analysis BIA measurements include (Weight ( kg), Muscle and fat mass (kg), Body bone and fluid mass (kg), such as). 2nd week
Primary Body Analysis BIA measurements include (Weight ( kg), Muscle and fat mass (kg), Body bone and fluid mass (kg), such as). 4th week
Primary Body Analysis BIA measurements include (Muscle and fat percentage (%) such as). Study start
Primary Body Analysis BIA measurements include (Muscle and fat percentage (%) such as). 2nd week
Primary Body Analysis BIA measurements include (Muscle and fat percentage (%) such as). 4th week
Primary Body Analysis BIA measurement include (Body density (mg/dl)). Study start
Primary Body Analysis BIA measurement include (Body density (mg/dl)). 2nd week
Primary Body Analysis BIA measurement include (Body density (mg/dl)). 4th week
Primary Body Analysis BIA measurement include (internal adiposity). Study start
Primary Body Analysis BIA measurement include (internal adiposity). 2nd week
Primary Body Analysis BIA measurement include (internal adiposity). 4th week
Primary Anthropometric Measurements It includes length (m) measurement. Study start
Primary Anthropometric Measurements It includes length (m) measurement. 2nd week
Primary Anthropometric Measurements It includes length (m) measurement. 4th week
Primary Anthropometric Measurements It includes waist (cm), hip (cm), upper arm (cm), thigh circumference (cm) and Skinfold thickness(cm) measurements. Study start
Primary Anthropometric Measurements It includes waist (cm), hip (cm), upper arm (cm), thigh circumference (cm) and Skinfold thickness(cm) measurements. 2nd week
Primary Anthropometric Measurements It includes waist (cm), hip (cm), upper arm (cm), thigh circumference (cm) and Skinfold thickness(cm) measurements. 4th week
Primary Anthropometric Measurements It includes waist-hip ratio measurements. Study start
Primary Anthropometric Measurements It includes waist-hip ratio measurements. 2nd week
Primary Anthropometric Measurements It includes waist-hip ratio measurements. 4th week
Primary Biochemical parameters It includes fasting blood sugar (mg/dL) value. Study start & 4th week
Primary Biochemical parameters It includes fasting blood sugar (mg/dL) value. Study start
Primary Biochemical parameters It includes HDL (mg/dL), LDL (mg/dL), TG (mg/dL), and Total cholesterol (mg/dL) values. 4th week
Primary Biophysical Methods It includes 5 X Sit-to-Stand Up test (sec). ( It show the temporal variation values in performing a certain activity. Functional activity and used to assess balance. Completion of test activity in a short time indicates positive development.) Study start
Primary Biophysical Methods It includes 5 X Sit-to-Stand Up test (sec). ( It show the temporal variation values in performing a certain activity. Functional activity and used to assess balance. Completion of test activity in a short time indicates positive development.) 2nd week
Primary Biophysical Methods It includes 5 X Sit-to-Stand Up test (sec). ( It show the temporal variation values in performing a certain activity. Functional activity and used to assess balance. Completion of test activity in a short time indicates positive development.) 4th week
Primary Biophysical Methods It includes the Stair Climb test (sec). ( It shows the temporal variation values in performing a particular activity. Functional activity and used to assess balance. Completion of test activity in a short time indicates positive development.) Study start
Primary Biophysical Methods It includes the Stair Climb test (sec). ( It shows the temporal variation values in performing a particular activity. Functional activity and used to assess balance. Completion of test activity in a short time indicates positive development.) 2nd week
Primary Biophysical Methods It includes the Stair Climb test (sec). ( It shows the temporal variation values in performing a particular activity. Functional activity and used to assess balance. Completion of test activity in a short time indicates positive development.) 4th week
Primary Biophysical Methods It includes The Timed Up and Go Test (sec). ( It show the temporal variation values in performing a certain activity. Functional activity and used to assess balance. Completion of test activity in a short time indicates positive development.) Study start
Primary Biophysical Methods It includes The Timed Up and Go Test (sec). ( It show the temporal variation values in performing a certain activity. Functional activity and used to assess balance. Completion of test activity in a short time indicates positive development.) 2nd week
Primary Biophysical Methods It includes The Timed Up and Go Test (sec). ( It show the temporal variation values in performing a certain activity. Functional activity and used to assess balance. Completion of test activity in a short time indicates positive development.) 4th week
Primary 6-Min Walk Test The 6-minute walk test includes value walking distance (m). (Increased walking distance indicates that functional values develop positively.) Study start
Primary 6-Min Walk Test The 6-minute walk test includes value walking distance (m). (Increased walking distance indicates that functional values develop positively.) 2nd week
Primary 6-Min Walk Test The 6-minute walk test includes value walking distance (m). (Increased walking distance indicates that functional values develop positively.) 4th week
Primary 6-Min Walk Test The 6-minute walk test includes value Blood pressure (mmHg) measurements. (High blood pressure measurements approaching the normal value indicate that functional values develop positively.) Study start
Primary 6-Min Walk Test The 6-minute walk test includes value Blood pressure (mmHg) measurements. (High blood pressure measurements approaching the normal value indicate that functional values develop positively.) 2nd week
Primary 6-Min Walk Test The 6-minute walk test includes value Blood pressure (mmHg) measurements. (High blood pressure measurements approaching the normal value indicate that functional values develop positively.) 4th week
Primary 6-Min Walk Test The 6-minute walk test includes value Modified Borg Dyspnea and Fatigue Scores. (Decreased dyspnea and fatigue scores indicate that functional values develop positively.) Study start
Primary 6-Min Walk Test The 6-minute walk test includes value Modified Borg Dyspnea and Fatigue Scores. (Decreased dyspnea and fatigue scores indicate that functional values develop positively.) 2nd week
Primary 6-Min Walk Test The 6-minute walk test includes value Modified Borg Dyspnea and Fatigue Scores. (Decreased dyspnea and fatigue scores indicate that functional values develop positively.) 4th week
Primary 6-Min Walk Test The 6-minute walk test includes value Heart Rate. (Heart rate values being within the normal range for age indicate that functional values develop positively.) Study start
Primary 6-Min Walk Test The 6-minute walk test includes value Heart Rate. (Heart rate values being within the normal range for age indicate that functional values develop positively.) 2nd week
Primary 6-Min Walk Test The 6-minute walk test includes value Heart Rate. (Heart rate values being within the normal range for age indicate that functional values develop positively.) 4th week
Primary 6-Min Walk Test The 6-minute walk test includes value O2 saturation (mmHg). (Increased O2 saturation indicates that functional values develop positively.) Study start
Primary 6-Min Walk Test The 6-minute walk test includes value O2 saturation (mmHg). (Increased O2 saturation indicates that functional values develop positively.) 2nd week
Primary 6-Min Walk Test The 6-minute walk test includes value O2 saturation (mmHg). (Increased O2 saturation indicates that functional values develop positively.) 4th week
Primary Handgrip strength test The Handgrip strength test (kg) measurement evaluates muscle strength. Study start
Primary Handgrip strength test The Handgrip strength test (kg) measurement evaluates muscle strength. 2nd week
Primary Handgrip strength test The Handgrip strength test (kg) measurement evaluates muscle strength. 4th week
Secondary International Physical Activity Questionnaire (Short Form- IPAQ) It has been used to examine physical activity levels. (Weekly physical activity levels are measured by MET value calculations. An increase in MET values indicates an increase in activity.) Study start, 2nd & 4th week
Secondary Quality of Life Questionnaire (Short Form - SF-36) It was used to evaluate the effect of weight on quality of life. (It is evaluated in the range of 0 - 100 points. Energy/vitality, physical function, mental health, general health perception, social functionality scores show a positive development as they approach the maximum value. Physical role difficulty, emotional role difficulty and Pain scores show a positive development as they approach the minimum value.) Study start, 2nd & 4th week
Secondary Food Cravings Questionnaire (FCQ) It was used to determine the cravings for foods. (In the scale, a scoring system between 39-234 points is used for sub-dimensions.It shows that there is a positive development as the scale approaches the minimum result.) Study start & 4th week
Secondary Visual Analog Scale (VAS) It was used to determine the cravings for foods. (A scoring system from 0 to 10 is used.It shows that there is a positive development as the scale approaches the minimum result.) Study start, 2nd & 4th week
See also
  Status Clinical Trial Phase
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2